<div id="readability-page-1"><p>Centene Co. (NYSE:CNC - Get Free Report) CEO Sarah London bought 4,117 shares of the business's stock in a transaction on Friday, November 8th. The shares were acquired at an average price of $60.80 per share, with a total value of $250,313.60. Following the transaction, the chief executive officer now owns 667,229 shares of the company's stock, valued at $40,567,523.20. The trade was a 0.00 % increase in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.</p><h2>Centene Trading Down 3.8 %</h2><ul><li>Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving</li></ul><p>Shares of NYSE:CNC traded down $2.38 during trading on Friday, reaching $60.14. 6,323,081 shares of the stock were exchanged, compared to its average volume of 3,938,904. The firm has a market cap of $30.36 billion, a price-to-earnings ratio of 10.44, a price-to-earnings-growth ratio of 0.88 and a beta of 0.49. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. Centene Co. has a 12-month low of $59.77 and a 12-month high of $81.42. The firm's 50-day moving average price is $69.71 and its 200 day moving average price is $71.58. </p><h2>Hedge Funds Weigh In On Centene</h2><p>Hedge funds and other institutional investors have recently made changes to their positions in the business. Park Place Capital Corp raised its position in  Centene by 1,190.0% in the third quarter. Park Place Capital Corp now owns 387 shares of the company's stock valued at $29,000 after purchasing an additional 357 shares during the period.  WR Wealth Planners LLC grew its stake in shares of  Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company's stock valued at $31,000 after buying an additional 137 shares in the last quarter.  Chris Bulman Inc acquired a new position in  Centene during the 2nd quarter worth approximately $33,000.  Riverview Trust Co boosted its holdings in  Centene by 154.6% in the 2nd quarter. Riverview Trust Co now owns 527 shares of the company's stock worth $35,000 after acquiring an additional 320 shares during the period.  Finally, Thurston Springer Miller Herd &amp; Titak Inc. acquired a new stake in  Centene in the second quarter valued at approximately $36,000. Institutional investors and hedge funds own  93.63% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><ul><li>Centene Reaffirms Guidance, But Is it Too Late?</li></ul><p>A number of equities research analysts recently issued reports on CNC shares. Stephens  reaffirmed an &#34;equal weight&#34; rating and issued a $78.00 target price on shares of Centene in a research note on Monday, August 5th. Wells Fargo &amp; Company decreased their price objective on Centene from $91.00 to $90.00 and set an &#34;overweight&#34; rating on the stock in a research note on Monday. Robert W. Baird cut their target price on shares of Centene from $83.00 to $66.00 and set a &#34;neutral&#34; rating for the company in a research note on Friday, October 25th. Barclays lowered their price target on shares of Centene from $97.00 to $91.00 and set an &#34;overweight&#34; rating for the company in a report on Tuesday, October 29th. Finally, Oppenheimer reduced their price objective on shares of Centene from $110.00 to $95.00 and set an &#34;outperform&#34; rating on the stock in a research note on Monday, July 29th. Seven investment analysts have rated the stock with a hold rating and eight have assigned  a buy rating to the stock. According to MarketBeat, Centene  has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $83.92.</p><p><b>Read Our Latest Stock Report on CNC</b></p><h2>Centene Company Profile</h2> (Get Free Report)<ul><li>Can UnitedHealth Group afford to keep Medicare Advantage plans?</li></ul><p>Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Centene</li><li>The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number</li><li>Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future</li><li>How is Compound Interest Calculated?</li><li>The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut</li><li>Conference Calls and Individual Investors</li><li>The Top 5 Performing S&amp;P 500 Stocks YTD in 2024</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ 2 sentences that change everything you THOUGHT you knew about trading <span><span>(From Investing Daily)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDY2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDY2"/></p><h2>Should you invest $1,000 in Centene right now?</h2><p>Before you consider Centene, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.</p><p>While Centene currently has a &#34;Moderate Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Centene Co. CEO Sarah London purchased 4,117 shares of the company's stock at an average price of $80 per share, totaling $313,560. Following this transaction, she now owns 667,229 shares valued at approximately $567,523.20, reflecting a 0.00% increase in her position. The stock recently traded down 3.8%, with a market cap of $36.36 billion. Analysts have mixed ratings on the stock, with a consensus target price of $92. Centene operates in healthcare, providing services to under-insured and uninsured families in the U.S.</p>

Centene Co. (NYSE:CNC) CEO Sarah London Buys 4,117 Shares